Cargando…

Sarm1 haploinsufficiency or low expression levels after antisense oligonucleotides delay programmed axon degeneration

Activation of the pro-degenerative protein SARM1 after diverse physical and disease-relevant injuries causes programmed axon degeneration. Original studies indicate that substantially decreased SARM1 levels are required for neuroprotection. However, we demonstrate, in Sarm1 haploinsufficient mice, t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gould, Stacey Anne, Gilley, Jonathan, Ling, Karen, Jafar-Nejad, Paymaan, Rigo, Frank, Coleman, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cell Press 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8692746/ https://www.ncbi.nlm.nih.gov/pubmed/34910914 http://dx.doi.org/10.1016/j.celrep.2021.110108

Ejemplares similares

Neurotoxin-mediated potent activation of the axon degeneration regulator SARM1
por: Loreto, Andrea, et al.
Publicado: (2021)

The NAD(+) precursor NMN activates dSarm to trigger axon degeneration in Drosophila
por: Llobet Rosell, Arnau, et al.
Publicado: (2022)

Absence of SARM1 Rescues Development and Survival of NMNAT2-Deficient Axons
por: Gilley, Jonathan, et al.
Publicado: (2015)

Antisense oligonucleotide therapy for KCNT1 encephalopathy
por: Burbano, Lisseth Estefania, et al.
Publicado: (2022)

Antisense oligonucleotide silencing of FUS expression as a therapeutic approach in amyotrophic lateral sclerosis
por: Korobeynikov, Vladislav A., et al.
Publicado: (2022)

Multifaceted roles of SARM1 in axon degeneration and signaling
por: Waller, Thomas J., et al.
Publicado: (2022)

Natural variants of human SARM1 cause both intrinsic and dominant loss-of-function influencing axon survival
por: Ademi, Mirlinda, et al.
Publicado: (2022)

Differential effects of SARM1 inhibition in traumatic glaucoma and EAE optic neuropathies
por: Liu, Pingting, et al.
Publicado: (2023)

Systemic loss of Sarm1 protects Schwann cells from chemotoxicity by delaying axon degeneration
por: Tian, Weili, et al.
Publicado: (2020)

TIR-1/SARM1 inhibits axon regeneration and promotes axon degeneration
por: Czech, Victoria L, et al.
Publicado: (2023)

Novel role of SARM1 mediated axonal degeneration in the pathogenesis of rabies
por: Sundaramoorthy, Vinod, et al.
Publicado: (2020)

A good gut feeling on Sarm1-mediated axon degeneration
por: von Saucken, Victoria E., et al.
Publicado: (2021)

SARM1 participates in axonal degeneration and mitochondrial dysfunction in prion disease
por: Lai, Meng-Yu, et al.
Publicado: (2022)

Antisense oligonucleotide therapy rescues disturbed brain rhythms and sleep in juvenile and adult mouse models of Angelman syndrome
por: Lee, Dongwon, et al.
Publicado: (2023)

Mitochondrial impairment activates the Wallerian pathway through depletion of NMNAT2 leading to SARM1-dependent axon degeneration
por: Loreto, Andrea, et al.
Publicado: (2020)

Scn8a Antisense Oligonucleotide Is Protective in Mouse Models of SCN8A Encephalopathy and Dravet Syndrome
por: Lenk, Guy M., et al.
Publicado: (2020)

The atlas of RNase H antisense oligonucleotide distribution and activity in the CNS of rodents and non-human primates following central administration
por: Jafar-nejad, Paymaan, et al.
Publicado: (2020)

SARM1 Depletion Slows Axon Degeneration in a CNS Model of Neurotropic Viral Infection
por: Crawford, Colin L., et al.
Publicado: (2022)

Longitudinal EEG model detects antisense oligonucleotide treatment effect and increased UBE3A in Angelman syndrome
por: Spencer, Elizabeth R., et al.
Publicado: (2022)

Gene therapy targeting SARM1 blocks pathological axon degeneration in mice
por: Geisler, Stefanie, et al.
Publicado: (2019)

SARM1 acts downstream of neuroinflammatory and necroptotic signaling to induce axon degeneration
por: Ko, Kwang Woo, et al.
Publicado: (2020)

Small Molecule SARM1 Inhibitors Recapitulate the SARM1(−/−) Phenotype and Allow Recovery of a Metastable Pool of Axons Fated to Degenerate
por: Hughes, Robert O., et al.
Publicado: (2021)

Blocking Wallerian degeneration by loss of Sarm1 does not promote axon resealing in zebrafish
por: Tian, Weili, et al.
Publicado: (2020)

Sarm1 activation produces cADPR to increase intra-axonal Ca(++) and promote axon degeneration in PIPN
por: Li, Yihang, et al.
Publicado: (2021)

Sarm1 Deletion, but Not Wld(S), Confers Lifelong Rescue in a Mouse Model of Severe Axonopathy
por: Gilley, Jonathan, et al.
Publicado: (2017)

NMNAT2 supports vesicular glycolysis via NAD homeostasis to fuel fast axonal transport
por: Yang, Sen, et al.
Publicado: (2023)

NMNAT1 inhibits axon degeneration via blockade of SARM1-mediated NAD(+) depletion
por: Sasaki, Yo, et al.
Publicado: (2016)

Sarm1 knockout protects against early but not late axonal degeneration in experimental allergic encephalomyelitis
por: Viar, Kenneth, et al.
Publicado: (2020)

SARM1 Suppresses Axon Branching Through Attenuation of Axonal Cytoskeletal Dynamics
por: Ketschek, Andrea, et al.
Publicado: (2022)

Meox2 Haploinsufficiency Accelerates Axonal Degeneration in DBA/2J Glaucoma
por: Buchanan, Rebecca A., et al.
Publicado: (2019)

Nonsense-mediated decay as a terminating mechanism for antisense oligonucleotides
por: Ward, Amanda J., et al.
Publicado: (2014)

Antisense-oligonucleotide-directed inhibition of nonsense-mediated mRNA decay
por: Nomakuchi, Tomoki T., et al.
Publicado: (2015)

SARM1 detection in myelinating glia: sarm1/Sarm1 is dispensable for PNS and CNS myelination in zebrafish and mice
por: Fazal, Shaline V., et al.
Publicado: (2023)

SARM1 Promotes Photoreceptor Degeneration in an Oxidative Stress Model of Retinal Degeneration
por: Gibbons, Luke, et al.
Publicado: (2022)

Antisense oligonucleotide therapy for spinocerebellar ataxia type 2
por: Scoles, Daniel R., et al.
Publicado: (2017)

Reduction of Kcnt1 is therapeutic in mouse models of SCN1A and SCN8A epilepsy
por: Hill, Sophie F., et al.
Publicado: (2023)

Manipulation of PK-M mutually exclusive alternative splicing by antisense oligonucleotides
por: Wang, Zhenxun, et al.
Publicado: (2012)

Structure-function analysis of ceTIR-1/hSARM1 explains the lack of Wallerian axonal degeneration in C. elegans
por: Khazma, Tami, et al.
Publicado: (2023)

Antisense Morpholino Oligonucleotides Reduce Neurofilament Synthesis and Inhibit Axon Regeneration in Lamprey Reticulospinal Neurons
por: Zhang, Guixin, et al.
Publicado: (2015)

MEK Inhibitor U0126 Reverses Protection of Axons from Wallerian Degeneration Independently of MEK–ERK Signaling
por: Evans, Catherine, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_9u8qc45ea5tffdf1omq5ucnpf0